NASDAQ:MDLN

Medline (MDLN) Stock Price, News & Analysis

Medline logo
$37.68 -1.49 (-3.80%)
Closing price 11/17/2026 04:00 PM Eastern
Extended Trading
$37.55 -0.13 (-0.34%)
As of 11/17/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Medline Stock (NASDAQ:MDLN)

Advanced

Key Stats

Today's Range
$37.56
▼
$39.45
50-Day Range
$31.64
▼
$42.16
52-Week Range
$31.37
▼
$50.88
Volume
9.07 million shs
Average Volume
10.96 million shs
Market Capitalization
$49.56 billion
P/E Ratio
32.37
Dividend Yield
N/A
Price Target
$46.08
Consensus Rating
Moderate Buy

Company Overview

Medline is a healthcare products manufacturer and distributor serving providers across the care continuum. Its customers include hospitals, surgery centers, physician practices, long-term care facilities and home-care organizations.

The company offers a broad range of medical and surgical supplies, including products for infection prevention, wound care and patient care, as well as apparel and equipment. Medline also provides supply-chain and logistics services to healthcare organizations.

Founded in 1966, Medline is headquartered in Northfield, Illinois, and serves customers in the United States and internationally. The company was built as a family business and has grown into a major supplier to the healthcare industry.

AI Generated. May Contain Errors.

Medline Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
76th Percentile Overall Score

MDLN MarketRank™: 
3.79473194093 of 5 stars

Medline scored higher than 76% of companies evaluated by MarketBeat, and ranked 253rd out of 859 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Medline has received a consensus rating of Moderate Buy. The company's average rating score is 2.72, and is based on no strong buy ratings, 23 buy ratings, 4 hold ratings, and 2 sell ratings.

  • Upside Potential

    Medline has a consensus price target of $46.08, representing about 22.3% upside from its current price of $37.68.

  • Amount of Analyst Coverage

    Medline has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Medline's stock forecast and price target.
  • Earnings Growth

    Earnings for Medline are expected to decrease by -8.23% in the coming year, from $1.58 to $1.45 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Medline is 32.37, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.44.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Medline is 32.37, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 32.76.

  • Price to Earnings Growth Ratio

    Medline has a PEG Ratio of 4.36. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Medline has a P/B Ratio of 2.56. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    2.90% of the float of Medline has been sold short.
  • Short Interest Ratio / Days to Cover

    Medline has a short interest ratio ("days to cover") of 3.79, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Medline has recently decreased by 7.29%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Medline does not currently pay a dividend.

  • Dividend Growth

    Medline does not have a long track record of dividend growth.

  • News Sentiment

    Medline has a news sentiment score of 0.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 13 news articles for Medline this week, compared to 9 articles on an average week.
  • Search Interest

    Only 9 people have searched for MDLN on MarketBeat in the last 30 days. This is a decrease of -25% compared to the previous 30 days.
  • MarketBeat Follows

    Only 2 people have added Medline to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Medline insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $224,525,137.00 in company stock.

  • Percentage Held by Insiders

    0.81% of the stock of Medline is held by insiders.

  • Percentage Held by Institutions

    Medline has minimal institutional ownership at this time.

  • Read more about Medline's insider trading history.
Receive MDLN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medline and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MDLN Stock News Headlines

My $247 scanner for $7
Bill Poulos is cutting the price of his $247 Instant Scanner to $7 for Black Friday. It's a one-time payment that covers a full year, with no subscription and no re-bills. Every night after the close, the scanner screens nearly a thousand of America's biggest stocks. It returns a short list of qualifying setups with the exact buy price next to each one. There's nothing to install. If you decide it's not for you, you get the $7 back and keep the scanner for the year.tc pixel
See More Headlines

MDLN Stock Analysis - Frequently Asked Questions

Medline's stock was trading at $42.00 on January 1st, 2026. Since then, MDLN stock has decreased by 10.3% and is now trading at $37.68.

Medline (NASDAQ:MDLN) announced its quarterly earnings results on Wednesday, November, 4th. The company reported $0.44 earnings per share for the quarter, topping the consensus estimate of $0.32 by $0.12. The firm had revenue of $7.86 billion for the quarter. Medline had a trailing twelve-month return on equity of 8.21% and a net margin of 1.84%.
Read the conference call transcript
.

Medline (MDLN) raised $7 billion in an IPO on Wednesday, December 17th 2025. The company issued 248,439,654 shares at a price of $26.00-$30.00 per share.

Top institutional investors of Medline include State Street Corp (0.75%), Banque Pictet & Cie SA (0.57%), Healthcare of Ontario Pension Plan Trust Fund (0.53%) and Durable Capital Partners LP (0.36%). Insiders that own company stock include Group Vii S1 LLC Tc, Aggregator Lp Mozart II, Cp Circle Ml Holdco Gp, Llc, Carlyle Group Inc, Mozart Coinvestment Ho Carlyle, Tc Group Cayman Investment Hol, Private Ltd Gic, Andrew J Mills, Charles N Mills, Hellman & Friedman Capital Par, Douglas P Golwas and Jessi L Corcoran.
View institutional ownership trends
.

Shares of MDLN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Medline investors own include NVIDIA (NVDA), Taiwan Semiconductor Manufacturing (TSM), Advanced Micro Devices (AMD), Oracle (ORCL), Broadcom (AVGO), Micron Technology (MU) and Netflix (NFLX).

Company Calendar

Last Earnings
11/04/2026
Today
11/17/2026
Jefferies Global Healthcare Conference
11/17/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Supplies
Current Symbol
NASDAQ:MDLN
CIK
2046386
Fax
N/A
Employees
45,000
Year Founded
1966

Price Target and Rating

High Price Target
$55.00
Low Price Target
$34.00
Potential Upside/Downside
+22.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.72
Research Coverage
29 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.44
Trailing P/E Ratio
32.37
Forward P/E Ratio
25.99
P/E Growth
4.36
Net Income
$1.16 billion
Net Margins
1.84%
Pretax Margin
3.64%
Return on Equity
8.21%
Return on Assets
4.03%

Debt

Debt-to-Equity Ratio
0.65
Current Ratio
4.04
Quick Ratio
2.51

Sales & Book Value

Annual Sales
$28.43 billion
Price / Sales
1.74
Cash Flow
$1.63 per share
Price / Cash Flow
23.09
Book Value
$14.74 per share
Price / Book
2.56

Miscellaneous

Outstanding Shares
1,315,320,000
Free Float
1,304,667,000
Market Cap
$49.56 billion
Optionable
Optionable
Beta
N/A

Social Links

The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

This page (NASDAQ:MDLN) was last updated on 11/17/2026 by MarketBeat.com Staff.
From Our Partners